Testimonials from initial use of the TREO FIT physician-modified endovascular graft highlight the system’s potential for ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...

Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.

he said. While these are relatively early data, Miller said ataciguat seems like it might eventually be an option for most patients with documented aortic stenosis, even those with bicuspid and ...

Veronica Even expected to bring her newborn, Theodore, home for Christmas. Instead, she watched as he was rushed to Manning ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMa ...

One of the revolutions in aortic valve disease has been Transcatheter ... with tailored approaches based on the patient’s unique anatomy, health status and risk factors, selecting the most ...

Experts discuss their experience using Philips LumiGuide; the value of 3D, color visualization; the learning curve; and its ...

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...